National Health Investors (NYSE:NHI) Sets New 12-Month Low – Time to Sell?

National Health Investors, Inc. (NYSE:NHI)’s share price reached a new 52-week low on Tuesday. The stock traded as low as $64.51 and last traded at $65.0710, with a volume of 20610 shares. The stock had previously closed at $65.02.

Analyst Ratings Changes

Several brokerages recently issued reports on NHI. Huntington began coverage on shares of National Health Investors in a research note on Thursday, September 10th. They issued an “outperform” rating and a $79.00 target price for the company. Truist Financial dropped their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, September 2nd. National Bank Financial set a $79.00 price objective on National Health Investors in a research report on Wednesday, September 9th. Zacks Research upgraded National Health Investors from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors has a consensus rating of “Moderate Buy” and a consensus target price of $82.25.

National Health Investors Stock Performance

The company’s fifty day simple moving average is $70.76 and its two-hundred day simple moving average is $75.07. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The stock has a market capitalization of $3.14 billion, a P/E ratio of 18.51, a PEG ratio of 3.50 and a beta of 0.49.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company’s revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities analysts forecast that National Health Investors, Inc. will post 4.76 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.7%. National Health Investors’s dividend payout ratio (DPR) is currently 108.67%.

Hedge Funds Weigh In On National Health Investors

Several institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in National Health Investors in the 2nd quarter worth about $665,997,000. Principal Financial Group Inc. increased its holdings in shares of National Health Investors by 2.0% during the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after purchasing an additional 32,902 shares during the period. Bank of New York Mellon Corp bought a new position in shares of National Health Investors during the second quarter worth approximately $122,509,000. Centersquare Investment Management LLC boosted its stake in shares of National Health Investors by 17.0% in the fourth quarter. Centersquare Investment Management LLC now owns 1,154,060 shares of the real estate investment trust’s stock valued at $88,136,000 after buying an additional 167,352 shares during the period. Finally, Bank of America Corp DE bought a new stake in shares of National Health Investors in the second quarter valued at approximately $77,738,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust that owns and finances healthcare-related real estate. The company primarily invests in properties used by seniors and patients, including senior housing communities, skilled nursing facilities, medical office buildings and other healthcare facilities.

NHI generally leases its properties to healthcare operators under long-term agreements and may provide mortgage or other financing to support the development and operation of healthcare real estate.